Originally designed to manage type 2 diabetes (T2D), these drugs have rapidly expanded their therapeutic reach, offering significant benefits for obesity, cardiovascular disease, and beyond
HbpA, haem-binding lipoprotein
The peptide is a disulfide-cyclized octamer and is reported to have agonist activity on both hMC3R (EC 50 = 1.61 nM, E max = 84%) and hMC4R (EC 50 = 0.280 nM, E max = 95%) as shown in Table 1 ( 50 = 4.2 nM, E max = 91%) and demonstrates enhanced hMC4R potency (EC 50 = 0.048 nM, E max = 100%) ( A phase I clinical trial to assess the safety of LY2112688 was conducted in the mid-late 2000s ( Table 2 )
What support is included in the WeightWatchers program besides meds
doi: 10.3389/fcell.2023.1254612 32
Allergy warning: Manufactured in a facility that processes products containing milk, soy, eggs, gluten, and nuts